Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00089323 · ClinicalTrials.gov registry record · NA

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

A NA study, sponsored by NSABP Foundation.

Completed
Registry status
NA
Development phase
1,630
Enrollment target

NCT00089323: Completed NA study, sponsored by NSABP Foundation.

NCT00089323 is a NA study that has completed, run by NSABP Foundation. The registered enrollment target is 1,630 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00089323, a NA study, has completed, sponsored by NSABP Foundation.

COMPLETED
Registry status
NA
Development phase
1,630 participants
Enrollment target

Study Summary

RATIONALE: Diagnostic procedures that detect tumor cells in the bone marrow may help doctors predict disease recurrence and plan more effective treatment. PURPOSE: This clinical trial is studying how well diagnostic procedures work in detecting tumor cells in the bone marrow of patients who have undergone surgery for stage I, stage II, or stage IIIA breast cancer.

Interventions

  • PROCEDURE Bone Marrow Aspiration

Trial Details

FieldValue
Enrollment Target 1,630 participants
Start Date 2007-01
Est. Completion 2018-08
Phase NA
NSABP Foundation

44 total trials

What the finished NCT00089323 record still lists

NCT00089323 is an interventional study that assigns participants to a tested intervention. Its 1,630 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher).

The record links to 0 conditions, and to 1 intervention - of which Bone Marrow Aspiration is the first listed.

NCT00089323 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00089323 about?

NCT00089323 is a clinical study titled "Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer". RATIONALE: Diagnostic procedures that detect tumor cells in the bone marrow may help doctors predict disease recurrence and plan more effective treatment. PURPOSE: This clinical trial is studying how well diagnostic procedures work in detecting tumor cells in the bone marrow of patients who have un...

What is the current status of trial NCT00089323?

This trial is currently completed. It is a NA study. The enrollment target is 1,630 participants. The study started on 2007-01. Estimated completion is 2018-08.

What interventions are being tested in trial NCT00089323?

The interventions under investigation include: Bone Marrow Aspiration (PROCEDURE).

Who is sponsoring clinical trial NCT00089323?

This trial is sponsored by NSABP Foundation, which has 44 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00089323's enrollment target sits among peer trials

1,630 63rd of 2000 higher than 1,938 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06959524 · 1,616 participants · NA

    AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

  • NCT04510129 · 1,650 participants

    A Multicenter Cancer Biospecimen Collection Study

  • NCT05612750 · 1,650 participants · NA

    Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

  • NCT06215716 · 1,650 participants · Phase 3

    A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00089323, the US trial registry maintained by the National Library of Medicine. NCT00089323 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.